Screening of Serum Protein Markers for Avascular Osteonecrosis of Femoral Head Differentially Expressed after Treatment with Yuanshi Shengmai Chenggu Tablets

Table 5

MRM was performed to verify the results obtained from iTRAQ proteomics.

Accession number	Description	Relative protein abundance (MRM)			Relative protein abundance (iTRAQ)
		SANFH versus healthy controls	SANFH-TCM versus healthy controls	SANFH-TCM versus SANFH	SANFH versus healthy controls	SANFH-TCM versus healthy controls	SANFH- TCM versus SANFH
P02671	Fibrinogen alpha	1.8493	62.3799	33.7321	0.95	7.502	7.849
P02675	Fibrinogen beta	3.2104	143.2262	44.6126	0.936	5.8	6.161
P02679	Fibrinogen gamma	1.7341	79.1554	45.6467	0.953	6.721	6.766
P02751	Fibronectin	0.8527	0.3081	0.3614	0.999	0.568	0.571
P02741	C-reactive protein	2.2723	0.522	0.2297	1.559	0.658	0.412
P06727	Apolipoprotein A	1.2723	1.8632	1.4644	1.06	1.532	1.45
P05090	Apolipoprotein D	0.9796	1.4369	1.4668	0.932	1.302	1.341
P02649	Apolipoprotein E	0.6693	0.6865	1.0257	0.759	0.713	0.934